Home / Pharmaceutical company intelligence
Don Valley logo
Pharmaceutical company intelligence

Don Valley

Pharmaceutical manufacturer and contract manufacturer · Lahore · Pakistan

Lahore-based generic and contract pharmaceutical manufacturer producing multiple dosage forms including penicillins, cephalosporins, injectables, solids, liquids and nutraceuticals.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Don Valley Pharmaceuticals
Company type
Pharmaceutical manufacturer and contract manufacturer
Address
31-KM Main Ferozepur Road, Lahore 54000, Pakistan · 54000
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
75%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000395 144 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx145public portfolio records represented
REG90unique registrations represented
IDX143indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR125current validated price records
G40generic molecules in indexed catalogue
DF8dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage86%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage96%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixDon ValleyShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026Anti-infectives76 · 53%Pain & musculoskeletal18 · 13%CNS & mental health12 · 8%Cardiovascular12 · 8%Hematology & thrombosis8 · 6%Respiratory & allergy5 · 3%Vitamins, minerals & nutrition4 · 3%Other therapeutic areas8 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioDon ValleyDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026143presentationsTablet77 · 54%Suspension28 · 20%Capsule19 · 13%Syrup9 · 6%Injection6 · 4%Lotion2 · 1%Other forms2 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionDon ValleyCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026133comparable productsBelow peer median33 · 25%Near peer median48 · 36%Above peer median52 · 39%Company median price position+2.1%Lowest-price equivalents6Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsDon ValleyCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026Mediate Pharmaceutical Pvt Ltd28 shared70% overlapNabiqasim Industries (Pvt) Ltd.,26 shared65% overlapMacter International Limited26 shared65% overlapWerrick Pharmaceuticals24 shared60% overlapZafa Pharmaceutical Laboratories (P…24 shared60% overlapAtco Laboratories Limited23 shared58% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives76 products · 53%
Pain & musculoskeletal18 products · 13%
CNS & mental health12 products · 8%
Cardiovascular12 products · 8%
Hematology & thrombosis8 products · 6%
Respiratory & allergy5 products · 3%
Vitamins, minerals & nutrition4 products · 3%
Gastrointestinal & hepatology4 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Penicillin antibacterials18 products · 13%
Analgesics / NSAIDs18 products · 13%
Third-generation cephalosporins13 products · 9%
Macrolide antibacterials11 products · 8%
Fluoroquinolone antibacterials9 products · 6%
Anticoagulants7 products · 5%
Antimalarials6 products · 4%
Antivirals5 products · 3%
Formulation footprint

Dosage forms

Tablet77 products
Suspension28 products
Capsule19 products
Syrup9 products
Injection6 products
Lotion2 products
Drops1 products
Ointment1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AmoxicapAmoxicillin 10presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Capsule #2 TylolParacetamol 9presentations 120 mg/5 mL, 500 mg · Suspension, Tablet #3 CefidonCefixime 7presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #4 DV-ZythroAzithromycin 7presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet #5 DV-CefCeftriaxone 6presentations 1 g, 250 MG, 250 mg, 500 mg · Injection #6 IbtolIbuprofen 6presentations 100 mg/5 mL, 200 mg, 400 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median3325% of comparable products
Near market median48within ±5% of median
Above market median5239% of comparable products
Lowest-price equivalents6ties included
Company median price position +2.1% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Devomycin 250 mgOxytetracycline · Capsule · 1's PKR 3.19/capsule-37.9% vs market median Empadon 10 mgEmpagliflozin · Tablet · 14's PKR 53.77/tablet-34.9% vs market median Angepine XR 300 mgQuetiapine · Extended-release tablet · 30’s PKR 91.43/tablet-33.0% vs market median Rofedon 600 mgRibavirin · Tablet · 100's PKR 16.57/tablet-32.7% vs market median Leptil 500 mgSodium valproate · Tablet · 50's PKR 8.64/tablet-31.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 28shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 26shared generics Macter International Limited256 products · 93 generics 26shared generics Werrick Pharmaceuticals249 products · 82 generics 24shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 24shared generics Atco Laboratories Limited278 products · 94 generics 23shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers89Distinct registrations among indexed, published, presentation-validated products only
Verified price observations144
Products with a verified price143
Products with multiple price observations1
Source records with multiple versions139
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

90 unique registration(s) · 143 indexed presentation(s) · 2 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
DV-Cef Ceftriaxone 250 mg IM injection 1 vial + 1 amp. 096719 PKR 186.51 — No comparator
DV-Cipro Ciprofloxacin 250 mg Tablet 100's 065690 PKR 2,422.97 PKR 24.23/tablet Near median
DV-Cipro Ciprofloxacin 250 mg Tablet 10's 065690 PKR 252.39 PKR 25.24/tablet Near median
DV-Cipro Ciprofloxacin 500 mg Tablet 100's 065691 PKR 4,000.37 PKR 40.00/tablet 7% below median
DV-Cipro Ciprofloxacin 500 mg Tablet 10's 065691 PKR 417.42 PKR 41.74/tablet Near median
DV-Losartan Losartan 25 mg Tablet 20's 028947 PKR 297.32 PKR 14.87/tablet 31% above median
DV-Losartan Losartan 50 mg Tablet 20's 028948 PKR 535.17 PKR 26.76/tablet 29% above median
DV-Losartan Losartan 100 mg Tablet 10's 069364 PKR 396.43 PKR 39.64/tablet 5% above median
DV-Quine Hydroxychloroquine 200 mg Tablet 50's 101893 PKR 830.96 PKR 16.62/tablet 15% above median
DV-Quine Hydroxychloroquine 200 mg Tablet 30's 101893 PKR 498.58 PKR 16.62/tablet 15% above median
DV-Zythro Azithromycin 500 mg Tablet 6's 104626 PKR 412.69 PKR 68.78/tablet 19% below median
DV-Zythro Azithromycin 500 mg Tablet 100's 104626 PKR 6,602.95 PKR 66.03/tablet 22% below median
DV-Zythro Azithromycin 500 mg Tablet 14's 104626 PKR 943.67 PKR 67.41/tablet 21% below median
DV-Zythro Azithromycin 250 mg Tablet 6's 104627 PKR 225.10 PKR 37.52/tablet 20% below median
DV-Zythro Azithromycin 250 mg Tablet 100's 104627 PKR 3,601.65 PKR 36.02/tablet 24% below median
DV-Zythro Azithromycin 200 mg/5 mL Suspension 30ml 104628 PKR 485.32 PKR 16.18/mL 26% below median
DV-Zythro Azithromycin 200 mg/5 mL Suspension 15ml 104628 PKR 247.61 PKR 16.51/mL 25% below median
Emapadon Empagliflozin 25 mg Tablet 14's 117778 PKR 1,510.49 PKR 107.89/tablet 8% above median
Empadon Empagliflozin 10 mg Tablet 14's 121448 PKR 752.78 PKR 53.77/tablet 35% below median
Evamox Acetazolamide 250 mg Tablet 30's 020294 PKR 328.65 PKR 10.96/tablet Near median
Ferimoz Iron polymaltose complex + Folic acid 50 mg + 0.35 mg/5 mL Syrup 60ml 069381 PKR 159.56 PKR 2.66/mL 34% above median
Ferimoz Iron polymaltose complex + Folic acid 100 mg + 0.35 mg Tablet 10's 071495 PKR 159.56 PKR 15.96/tablet 21% above median
Ferital Iron protein succinylate 800 mg/15 mL (equiv. 40 mg elemental iron) Syrup 60ml 023915 PKR 188.30 PKR 3.14/mL 6% above median
Ferital Iron protein succinylate 800 mg/15 mL (equiv. 40 mg elemental iron) Syrup 120ml 023915 PKR 297.32 PKR 2.48/mL 19% below median
Fluxine Fluoxetine 20 mg Capsule 7's 020295 PKR 513.71 PKR 73.39/capsule 466% above median
Fluxine Fluoxetine 20 mg Capsule 14's 020295 PKR 1,006.86 PKR 71.92/capsule 455% above median
Fluxine Fluoxetine 20 mg Capsule 28's 020295 PKR 1,972.66 PKR 70.45/capsule 443% above median
HypresTablet Amlodipine 5 mg Tablet 20's 021868 PKR 275.50 PKR 13.78/tablet 27% above median
Ibtol Ibuprofen 100 mg/5 mL Suspension 90ml 057508 PKR 87.52 PKR 0.97/mL Near median
Ibtol Ibuprofen 100 mg/5 mL Suspension 100ml 057508 PKR 97.41 PKR 0.97/mL Near median
Ibtol Ibuprofen 100 mg/5 mL Suspension 120ml 057508 PKR 135.50 PKR 1.13/mL 19% above median
Ibtol Ibuprofen 100 mg/5 mL Suspension 60ml 057508 PKR 53.57 PKR 0.89/mL 6% below median
Ibtol Ibuprofen 200 mg Tablet 100's 057509 PKR 266.65 PKR 2.67/tablet 18% above median
Ibtol Ibuprofen 400 mg Tablet 100's 127427 PKR 357.86 PKR 3.58/tablet Near median
Kavelex Cephalexin 100 mg/1 mL Oral drops 10ml 017388 PKR 146.68 PKR 14.67/mL No comparator
Kavelex Cephalexin 125 mg/5 mL Suspension 60ml 017389 PKR 116.95 PKR 1.95/mL 5% above median
Kavelex Cephalexin 250 mg/5 mL Suspension 60ml 017390 PKR 202.18 PKR 3.37/mL 5% above median
Kavelex Cephalexin 250 mg Capsule 12's 017391 PKR 202.18 PKR 16.85/capsule 10% above median
Kavelex Cephalexin 500 mg Capsule 12's 017392 PKR 396.43 PKR 33.04/capsule 7% above median
Leptil Sodium valproate 200 mg Tablet 50's 021871 PKR 235.61 PKR 4.71/tablet Near median
Leptil Sodium valproate 500 mg Tablet 100's 021872 PKR 1,323.73 PKR 13.24/tablet 50% above median
Leptil Sodium valproate 500 mg Tablet 30's 021872 PKR 405.34 PKR 13.51/tablet 54% above median
Leptil Sodium valproate 500 mg Tablet 50's 021872 PKR 431.97 PKR 8.64/tablet 32% below median
Leptil Sodium valproate 250 mg/5 mL Syrup 120ml 021873 PKR 220.04 PKR 1.83/mL Near median
Lipostat Simvastatin 10 mg Tablet 10's 026241 PKR 389.24 PKR 38.92/tablet 34% above median
Lipostat Simvastatin 20 mg Tablet 10's 026242 PKR 625.15 PKR 62.52/tablet 37% above median
Lipostat Simvastatin 40 mg Tablet 10's 028004 PKR 961.02 PKR 96.10/tablet 33% above median
Losazid Plus Losartan + Hydrochlorothiazide 50 mg + 12.5 mg Tablet 28's 069383 PKR 732.01 PKR 26.14/tablet 15% below median
Losazid Plus Losartan + Hydrochlorothiazide 50 mg + 12.5 mg Tablet 20's 069383 PKR 594.64 PKR 29.73/tablet Near median
Lovenox Levofloxacin 250 mg Tablet 100's 069370 PKR 4,659.54 PKR 46.60/tablet Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Don Valley — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 22, 2026, from https://medinfobase.com/company/don-valley/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.